Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911831 · ClinicalTrials.gov registry record · Early Phase 1
IV Tranexamic Acid Prior to Hysterectomy
A Early Phase 1 study, sponsored by Northwestern University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 71
- Enrollment target
NCT02911831: Completed Early Phase 1 study, sponsored by Northwestern University.
NCT02911831 is a Early Phase 1 study that has completed, run by Northwestern University. The registered enrollment target is 71 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (34% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02911831, a Early Phase 1 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effect of 1g of IV tranexamic acid given within 1 hour pre-operatively on intraoperative blood loss at time of hysterectomy.
Interventions
- DRUG Tranexamic Acid
- DRUG Sodium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-04 |
| Phase | Early Phase 1 |
What the finished NCT02911831 record still lists
NCT02911831 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (34% higher).
The record links to 0 conditions, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT02911831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02911831 about?
NCT02911831 is a clinical study titled "IV Tranexamic Acid Prior to Hysterectomy". The objective of this study is to determine the effect of 1g of IV tranexamic acid given within 1 hour pre-operatively on intraoperative blood loss at time of hysterectomy.
What is the current status of trial NCT02911831?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 71 participants. The study started on 2016-11. Estimated completion is 2022-04.
What interventions are being tested in trial NCT02911831?
The interventions under investigation include: Tranexamic Acid (DRUG), Sodium Chloride (DRUG).
Who is sponsoring clinical trial NCT02911831?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02911831's enrollment target sits among peer trials
71 328th of 2000 higher than 1,662 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia